According to Xvivo Perfusion AB's latest financial reports the company's current revenue (TTM ) is €62.84 Million. In 2023 the company made a revenue of €51.29 Million an increase over the revenue in the year 2022 that were of €37.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.